Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 11 1001-1005, Copyright © 1998 by American Association for Cancer Research

ARTICLES

Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study

DM Gertig, M Stampfer, C Haiman, CH Hennekens, K Kelsey and DJ Hunter
Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.

Glutathione S-transferase (GST) M1 and T1 genes encode GST enzymes, and are polymorphic in humans. These enzymes catalyze conjugation with glutathione, which is an important step in the detoxification of certain carcinogens. Several case-control studies have found associations of the homozygous null deletions in GSTM1 and GSTT1 with increasing the risk of colorectal and lung cancer. We prospectively examined the associations of the GSTM1 and GSTT1 polymorphisms with colorectal cancer risk in a nested case-control study (212 cases of colorectal cancer and 221 controls) within the Physicians' Health Study. Among controls, the prevalence of the GSTM1 homozygous null genotype was 53% and for GSTT1 homozygous null genotype, 23%. We found no increase in the risk of colorectal cancer for either GSTM1 null [odds ratio (OR) = 1.0; 95% confidence interval (CI), 0.7-1.5] or GSTT1 null (OR = 0.8; 95% CI, 0.5-1.2) genotypes. No differences were seen by site of colon cancer (proximal versus distal) or by age (< or = 60 years versus > 60 years). Current cigarette smokers with GSTM1 null genotype were not at an increased risk of colon cancer (OR = 1.2; 95% CI, 0.3-4.2) compared with current smokers without the null genotype; for the GSTT1 null genotype this OR was 1.1 = 95% CI (0.3-4.7). This lack of association persisted when we examined pack-years of smoking and age at starting smoking. Our results do not support an association of GSTM1 or GSTT1 polymorphisms with colorectal cancer or an interaction with cigarette smoking.

This article has been cited by other articles:

				M. Luchtenborg, M. P. Weijenberg, E. Kampman, G. N. van Muijen, G. M. J. M. Roemen, M. P. A. Zeegers, R. A. Goldbohm, P. van 't Veer, A. F. P. M. de Goeij, and P. A. van den Brandt Cigarette Smoking and Colorectal Cancer: APC Mutations, hMLH1 Expression, and GSTM1 and GSTT1 Polymorphisms Am. J. Epidemiol., May 1, 2005; 161(9): 806 - 815. [Abstract] [Full Text] [PDF]

				M. L. Slattery, S. Edwards, K. Curtin, D. Schaffer, and S. Neuhausen Associations between Smoking, Passive Smoking, GSTM-1, NAT2, and Rectal Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 882 - 889. [Abstract] [Full Text] [PDF]

				A. Seow, J.-M. Yuan, C.-L. Sun, D. Van Den Berg, H.-P. Lee, and M. C. Yu Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study Carcinogenesis, December 1, 2002; 23(12): 2055 - 2061. [Abstract] [Full Text] [PDF]

				M. M. de Jong, I. M. Nolte, G. J. te Meerman, W. T. A. van der Graaf, E. G. E. de Vries, R. H. Sijmons, R. M. W. Hofstra, and J. H. Kleibeuker Low-penetrance Genes and Their Involvement in Colorectal Cancer Susceptibility Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1332 - 1352. [Abstract] [Full Text] [PDF]

				C P Strassburg, A Vogel, S Kneip, R H Tukey, and M P Manns Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer Gut, June 1, 2002; 50(6): 851 - 856. [Abstract] [Full Text] [PDF]

				S. A. Geisler and A. F. Olshan GSTM1, GSTT1, and the Risk of Squamous Cell Carcinoma of the Head and Neck: A Mini-HuGE Review Am. J. Epidemiol., July 15, 2001; 154(2): 95 - 105. [Abstract] [Full Text] [PDF]

				A. Loktionov, M. A. Watson, M. Gunter, W. S.L. Stebbings, C. T.M. Speakman, and S. A. Bingham Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor Carcinogenesis, July 1, 2001; 22(7): 1053 - 1060. [Abstract] [Full Text] [PDF]